NCT01851746Unknown不适用
A Study of Docetaxel and Lobaplatin vs. Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
Wuhan University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Evidence of the effectiveness and security of lobaplatin combined with docetaxel in treatment of the sensitive recurrent ovarian cancer.
研究概览
简要总结
The purpose of this study is to evaluate the effectiveness and security of lobaplatin combined with docetaxel in treatment of the sensitive recurrent ovarian cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •age between 18 and 70 years old
- •singed the information consent form
- •Expected survival time >3 months
- •Recurrence for at least 6 months after receiving initial platinum-based chemotherapy and without cytoreductive surgery indications.
排除标准
- •Recurrence within 6 months after receiving initial platinum-based chemotherapy
- •without radiographic evidence for tumor recurrence
- •receiving other chemotherapy, hormone therapy, immunotherapy, or radiation therapy
结局指标
主要结局
Evidence of the effectiveness and security of lobaplatin combined with docetaxel in treatment of the sensitive recurrent ovarian cancer.
时间窗: from pre-chemotherapy to 4-6 weeks post-chemotherapy
Blood routine, urine routine, hepatic and kidney function, electrolyte, ECG, CT,MRI
次要结局
未报告次要终点
研究者
HB Cai
Director of gynecologic oncology department of Zhongnan Hospital of Wuhan University
Wuhan University
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerProstate CancerNCT00134706Dana-Farber Cancer Institute30
已完成
2 期
Docetaxel+Oxali+/-Cetux Met Gastric/GEJGastric Cancer Adenocarcinoma MetastaticNCT00517829US Oncology Research150
Unknown
2 期
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHNLocally Advanced Head and Neck Squamous Cell CarcinomaNCT03117257Guiyang Medical University144
终止
2 期
A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic IrradiationAdvanced Endometrial Adenocarcinoma, Stage III A, B, CNCT00285415Carilion Clinic46
Unknown
2 期
Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal CarcinomaNasopharyngeal CarcinomaNCT02610556Sun Yat-sen University130